RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Foster, David A.
Item TypeName
Academic Article Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.
Academic Article Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.
Academic Article Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
Academic Article Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle.
Academic Article High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.
Academic Article Inhibition of S6 kinase suppresses the apoptotic effect of eIF4E ablation by inducing TGF-?-dependent G1 cell cycle arrest.
Academic Article Rapamycin-induced G1 cell cycle arrest employs both TGF-? and Rb pathways.
Academic Article Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
Academic Article Phospholipase D confers rapamycin resistance in human breast cancer cells.
Academic Article The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival.
Academic Article Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Academic Article mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.
Academic Article Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
Academic Article Suppression of TGF-beta signaling by phospholipase D.
Academic Article Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Concept Oxidative Phosphorylation
Concept Phosphorylation
Academic Article Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.
Search Criteria
  • Phosphorylation
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support